Diabetologia – about the journal
Understand more about our journal Diabetologia. Find further information by visiting our website www.diabetologia-journal.org.
Ask Me Anything: Do You Read the Cover Letter?
Editor Hindrik Mulder answers your FAQs.
Interview with Torben Hansen July 2021
Our interview with author Torben Hansen about the research in a Greenlandic population cohort behind new publication: Physical activity attenuates postprandial hyperglycaemia in homozygous TBC1D4 loss-of-function mutation carriers Theresia M. Schnurr, Emil Jørsboe, Alexandra Chadt, Inger K. Dahl-Petersen, Jonas M. Kristensen, Jørgen F. P. Wojtaszewski, Christian Springer, Peter Bjerregaard, Søren Brage, Oluf Pedersen, Ida Moltke, Niels Grarup, Hadi Al-Hasani, Anders Albrechtsen, Marit E. Jørgensen & Torben Hansen
In Our Hands
The Diabetologia team explains why you should put your paper in our hands.
How do you say: Diabetologia?
Professor Dana Dabelea discusses her 2019 paper Developmental overnutrition and obesity and type 2 diabetes in offspring (10.1007/s00125-019-4914-1).
Management of hyperglycaemia in type 2 diabetes. 2018 EASD–ADA guidelines
Professors Melanie Davies and Chantal Mathieu discuss the 2018 EASD-ADA guidelines on the management of hyperglycaemia in type 2 diabetes (10.1007/s00125-018-4729-5).
Professor Christoph Wanner talks about his 2018 Diabetologia paper on the future of SGLT2 inhibitors for the treatment of type 2 diabetes and other chronic diseases (10.1007/s00125-018-4678-z).
David Cherney and Merlin Thomas
Dr David Cherney and Dr Merlin Thomas discuss their 2018 Diabetologia paper on the actions of SGLT2 inhibitors on metabolism, renal function and blood pressure (10.1007/s00125-018-4669-0).
Gian Paolo Fadini
Professor Fadini discusses his 2017 Diabetologia paper on SGLT2 inhibitors and diabetic ketoacidosis (10.1007/s00125-017-4301-8).
Dr Jordana Bell discusses the importance of the human gut microbiome in diabetes.
Professor Susanne Ullrich discusses her 2017 Diabetologia paper 'Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion' (10.1007/s00125-017-4385-1).
Professor Silvio Inzucchi discusses his 2018 Diabetologia paper weighing up the risks and benefits of the use of SGLT2 inhibitors in type 2 diabetes (10.1007/s00125-018-4663-6).
Dr Nicolaas Schaper talks about his 2017 Diabetologia paper: Breaking sitting with light activities vs structured exercise: a randomised crossover study demonstrating benefits for glycaemic control and insulin sensitivity in type 2 diabetes (10.1007/s00125-016-4161-7).